A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan : amino acid substitutions in HCV core region as predictor of sustained virological response

Bibliographic Information

Title
A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan : amino acid substitutions in HCV core region as predictor of sustained virological response
Author
芥田憲夫

Journal

Related Projects

See more

Details 詳細情報について

  • CRID
    1010282257061527696
  • Article Type
    journal article
  • Data Source
    • KAKEN

Report a problem

Back to top